ARDEA BIOSCIENCES, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 107
- Market Cap
- -
- Website
- http://www.ardeabio.com
RDEA3170 and Febuxostat Combination Study in Gout Subjects
Phase 2
Completed
- Conditions
- Gout
- Interventions
- Drug: RDEA3170 10 mgDrug: RDEA3170 15 mgDrug: RDEA3170 2.5Drug: RDEA3170 5 mg
- First Posted Date
- 2014-09-23
- Last Posted Date
- 2017-07-27
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT02246673
Mild, Moderate and Severe Renal Impairment Study
- First Posted Date
- 2014-08-19
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT02219516
Lesinurad Tablet Bioequivalence
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2014-09-22
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT02127775
Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: [14C]lesinurad (100 μg per 10 mL)
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02039700
Metformin and Furosemide Drug-Drug Interaction Study
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2014-02-14
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT02028689
Lesinurad Tablet Relative Bioavailability
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2014-09-22
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01986556
Antacid Interaction Study
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-11-13
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01982201
RDEA3170 Monotherapy in Subjects With Gout
Phase 2
Completed
- Conditions
- Gout
- Interventions
- Drug: PlaceboDrug: RDEA3170 5 mgDrug: RDEA3170 10 mgDrug: RDEA3170 12.5 mg
- First Posted Date
- 2013-08-22
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 172
- Registration Number
- NCT01927198
RDEA3170 AME Study
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: RDEA3170 10 mg
- First Posted Date
- 2013-07-29
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01910506
Lesinurad Interaction Study With Ranitidine
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-07-25
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT01908257